2m 2m 2m 2m 2m 2m 2m
ZENTALIS PHARMA (ZNTL)
NASDAQ
$3.81+$0.09 (+2.39%)
Price as of Jun 03, 2026 7:53 PM EDT- $284.7MMarket Cap
- 190.44%1-Year Change
- BiotechnologyIndustry
ZENTALIS PHARMA (ZNTL)
$3.81+$0.09 (+2.39%)
ZNTL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.72 | ||
Change | -$0.03 (-0.75%) | ||
Open | $3.91 | ||
High | $3.94 | ||
Low | $3.62 | ||
Previous Close | $3.95 | ||
Volume | 1,153,461 | ||
30-Day Average Volume | 975,296 | ||
1-Week Change | -0.25% | ||
1-Month Change | -3.42% | ||
1-Year Change | 190.44% | ||
3-Year Change | -84.96% | ||
5-Year Change | -92.65% | ||
Fundamentals | |||
Shares Outstanding | 71.2M | ||
Total Assets | $253.1M | ||
Market Cap | $284.7M | ||
Enterprise Value | $252.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$35.4M | ||
Free Cash Flow | -$33.0M | ||
EBIT | -$35.2M | ||
EBITDA | -$35.1M | ||
Net Working Capital | $182.9M | ||
EPS | -$0.50 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -8 | ||
PEG | 5 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue